MedElevator
Войти в исследования Gynecologic oncology · 2026
Failure to rescue after major gynecologic cancer surgery: A National Surgical Quality Improvement Program analysis.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Farabee Elizabeth A, Ahrendt Hannah D, Lin Michelle, Uczkowski Natalia Gontarczyk, Godecker Amy L, Wallace Sumer K
Аннотация
OBJECTIVE: Failure to rescue (FTR), defined as mortality following a postoperative complication, is a more comprehensive quality metric than complication or mortality rates alone. This study evaluated the incidence of FTR and associated risk factors in major gynecologic oncology surgery.
METHODS: The American College of Surgeons National Surgical Quality Improvement Program was queried for patients undergoing gynecologic oncology procedures between 2013 and 2019 and 2022-2024; data from 2020 to 2021 were excluded due to pandemic-related disruption. Primary outcome was FTR, defined as death within 30 days among patients with at least one postoperative complication. Multivariable logistic regression was used to adjust for factors associated with FTR.
RESULTS: Among 100,054 patients undergoing major gynecologic oncology surgery, 5.5% experienced one or more postoperative complications and the overall FTR rate was 4.8%. Procedure was not independently associated with FTR. On multivariable analysis, any severe complication was most strongly associated with FTR (OR 4.73, 95% CI 3.45-6.50). In the adjusted model, hypoalbuminemia (OR 2.84, 95% CI 2.07-3.89), perioperative transfusion (OR 1.63, 95% CI 1.17-2.27), and increasing age (OR 1.03 per year, 95% CI 1.02-1.04) were also significantly associated with FTR. Patients who experienced FTR had earlier time to first complication and earlier reoperation compared with survivors.
CONCLUSIONS: Complication severity, and markers of reduced physiologic reserve, rather than procedure complexity, are the patient-level factors driving FTR following major gynecologic cancer surgery. These findings support targeted preoperative optimization and intensified postoperative surveillance for high-risk patients.
METHODS: The American College of Surgeons National Surgical Quality Improvement Program was queried for patients undergoing gynecologic oncology procedures between 2013 and 2019 and 2022-2024; data from 2020 to 2021 were excluded due to pandemic-related disruption. Primary outcome was FTR, defined as death within 30 days among patients with at least one postoperative complication. Multivariable logistic regression was used to adjust for factors associated with FTR.
RESULTS: Among 100,054 patients undergoing major gynecologic oncology surgery, 5.5% experienced one or more postoperative complications and the overall FTR rate was 4.8%. Procedure was not independently associated with FTR. On multivariable analysis, any severe complication was most strongly associated with FTR (OR 4.73, 95% CI 3.45-6.50). In the adjusted model, hypoalbuminemia (OR 2.84, 95% CI 2.07-3.89), perioperative transfusion (OR 1.63, 95% CI 1.17-2.27), and increasing age (OR 1.03 per year, 95% CI 1.02-1.04) were also significantly associated with FTR. Patients who experienced FTR had earlier time to first complication and earlier reoperation compared with survivors.
CONCLUSIONS: Complication severity, and markers of reduced physiologic reserve, rather than procedure complexity, are the patient-level factors driving FTR following major gynecologic cancer surgery. These findings support targeted preoperative optimization and intensified postoperative surveillance for high-risk patients.